| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |